BPCIA Complaint Against Proposed Rituxan® Biosimilar DRL_RI Filed - Patent

On November 17, 2023, Genentech, Inc., Hoffmann-La Roche Inc., and Biogen Inc. ("Plaintiffs") filed a BPCIA complaint ("Complaint") against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories SA ("DRL SA")...

Related Keywords

United States ,New Jersey ,Fresenius Kabi Deutschland Gmb ,April Breyer Menon ,Sandoz Gmb ,Sanofi Aventis Deutschland Gmb ,Fresenius Kabi Swissbiosim ,Roche Inc ,Fresenius Kabi United States ,Celltrion Healthcare Co Ltd ,Reddy Laboratories Inc ,Genentech ,Celltrion Healthcare Co ,Biogen Inc ,Biogen Idec Inc ,Genentech Inc ,Hoffmann La Roche Inc ,Fresenius Kabi Deutschland Gmbh ,Sanofi Aventis Deutschland Gmbh ,Commercial Marketing ,Mondaq ,Bpcia Complaint Against Proposed Rituxan Xae Biosimilar Drl Ri Filed ,Food ,Drugs ,Healthcare ,Life Sciences ,Iotechnology Amp Nanotechnology ,Intellectual Property ,Patent , ,